Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PET-CT and DWI-MRI in Evaluating and Predicting Response to Neo-adjuvant Chemoradiotherapy in Esophageal Cancer Patients

NCT02839109 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT02839109
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02839109 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PET-CT and DWI-MRI in Evaluating and Predicting Response to Neo-adjuvant Chemoradiotherapy in Esophageal Cancer Patients
Lead sponsor
University Medical Center Groningen
Phase
Observational
Overall status
Completed
Start date
February 28, 2015
Completion date
August 31, 2017
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal tumor